NO20020043D0 - Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons - Google Patents

Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons

Info

Publication number
NO20020043D0
NO20020043D0 NO20020043A NO20020043A NO20020043D0 NO 20020043 D0 NO20020043 D0 NO 20020043D0 NO 20020043 A NO20020043 A NO 20020043A NO 20020043 A NO20020043 A NO 20020043A NO 20020043 D0 NO20020043 D0 NO 20020043D0
Authority
NO
Norway
Prior art keywords
anticoagulant
surrogate markers
patient
treating
prevent
Prior art date
Application number
NO20020043A
Other languages
English (en)
Norwegian (no)
Inventor
John Mcmichael
Original Assignee
Rxfiles Net Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rxfiles Net Corp filed Critical Rxfiles Net Corp
Publication of NO20020043D0 publication Critical patent/NO20020043D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
NO20020043A 1999-07-06 2002-01-04 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons NO20020043D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/348,592 US6267116B1 (en) 1999-07-06 1999-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
PCT/US2000/018576 WO2001002050A2 (en) 1999-07-06 2000-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Publications (1)

Publication Number Publication Date
NO20020043D0 true NO20020043D0 (no) 2002-01-04

Family

ID=23368686

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20020043A NO20020043D0 (no) 1999-07-06 2002-01-04 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons
NO20020056A NO20020056D0 (no) 1999-07-06 2002-01-07 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20020056A NO20020056D0 (no) 1999-07-06 2002-01-07 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons

Country Status (15)

Country Link
US (2) US6267116B1 (pt)
EP (1) EP1191894B1 (pt)
JP (1) JP2003503165A (pt)
KR (1) KR20020036790A (pt)
CN (1) CN1359276A (pt)
AT (1) ATE378015T1 (pt)
AU (1) AU5919800A (pt)
BR (1) BR0012241A (pt)
CA (1) CA2362429C (pt)
DE (1) DE60037116T2 (pt)
IL (1) IL147201A0 (pt)
MX (1) MXPA01013306A (pt)
NO (2) NO20020043D0 (pt)
TR (1) TR200103831T2 (pt)
WO (1) WO2001002050A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
EP1311202A4 (en) * 2000-08-24 2007-04-18 Dimensional Dosing Systems Inc METHOD AND DEVICE FOR THE REVISION OF THE ANTIKOAGULANTDOSIS
US6578582B2 (en) * 2001-08-24 2003-06-17 The Rxfiles Corporation Method and apparatus using IDS™ for multi-agent therapy
US6883521B2 (en) * 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
WO2003026727A1 (en) * 2001-09-28 2003-04-03 Lifevent Limited sETHOD AND APPARATUS FOR DELIVERY OF MEDICATION
US20050154537A1 (en) * 2003-12-12 2005-07-14 Kutzko John D. Methods, program products, and systems for single and multi-agent dosing and other related methods
EP1862233B1 (en) * 2006-06-01 2011-02-02 Wila B.V. Tool with an automatic safety click
ES2362106T3 (es) * 2006-06-01 2011-06-28 Wila B.V. Combinación de una herramienta intercambiable y un elemento manipulador.
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US8112290B2 (en) * 2008-05-16 2012-02-07 Adolor Corporation Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
US8688416B2 (en) * 2008-10-20 2014-04-01 Michael Fearon Methods and systems for improved pharmaceutical intervention in coagulation control
WO2011163506A2 (en) 2010-06-23 2011-12-29 University Of Louisville Research Foundation, Inc. Methods and kits for predicting a response to an erythropoietic agent
WO2013049624A1 (en) 2011-09-30 2013-04-04 University Of Louisville Research Foundation, Inc. System and method for personalized dosing of pharmacologic agents
SG11201502616WA (en) 2012-10-05 2015-05-28 Baysient LLC System and method for providing patient-specific dosing as a function of mathematical models
CA2988724C (en) 2015-04-09 2023-10-10 Diane R. Mould Systems and methods for patient-specific dosing
US20190043501A1 (en) * 2017-08-02 2019-02-07 Elements of Genius, Inc. Patient-centered assistive system for multi-therapy adherence intervention and care management
US12046341B2 (en) * 2021-10-05 2024-07-23 Bradford Rabin Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen
KR20240033436A (ko) 2022-09-05 2024-03-12 박세경 휴대용 머신러닝 기반의 약물 부작용 탐지 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5365948A (en) * 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug

Also Published As

Publication number Publication date
MXPA01013306A (es) 2002-07-02
IL147201A0 (en) 2002-08-14
EP1191894B1 (en) 2007-11-14
AU5919800A (en) 2001-01-22
US6267116B1 (en) 2001-07-31
WO2001002050A3 (en) 2002-01-10
NO20020056L (no) 2002-01-07
DE60037116D1 (de) 2007-12-27
ATE378015T1 (de) 2007-11-15
NO20020056D0 (no) 2002-01-07
CA2362429A1 (en) 2001-01-11
CN1359276A (zh) 2002-07-17
US6942614B1 (en) 2005-09-13
KR20020036790A (ko) 2002-05-16
WO2001002050A2 (en) 2001-01-11
JP2003503165A (ja) 2003-01-28
BR0012241A (pt) 2002-03-26
TR200103831T2 (tr) 2002-10-21
DE60037116T2 (de) 2008-09-11
CA2362429C (en) 2005-07-05
EP1191894A4 (en) 2004-10-20
EP1191894A2 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
NO20020043D0 (no) Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons
NO996229L (no) Heparanase spesifikke molekylære prober og deres anvendelse i forskning og medisin
ATE412445T1 (de) Stimulationssystem
HUP9802264A2 (hu) A vér oxigénszintjének mérésére szolgáló rendszer
Michael et al. The risk of bladder calculi in patients with spinal cord injuries
DE60011274D1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
SE9103332L (sv) Metod foer diagnos av blodkoagulationssjukdomar
WO2003011215A3 (en) Method and system to determine revised dosage
Rotstein et al. Effect of chloroform, xylene, and halothane on enamel and dentin microhardness of human teeth
WO2002082972A3 (en) Method and apparatus to optimize drug therapy
SE0102147D0 (sv) New methods
Goebel Reliability of the medical history in identifying patients likely to place dentists at an increased hepatitis risk
Troulis et al. Dental extractions in patients on an oral anticoagulant: a survey of practices in North America
EP1563308A4 (en) METHOD AND KITS FOR TUMORIGENICITY DIAGNOSIS
EP1318474A3 (en) Counter mechanisms
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
ES2095337T3 (es) Preparacion de pranoprofen de liberacion sostenida.
Levin et al. A controlled comparison of involuntarily hospitalized medication refusers and acceptors
Becker et al. Anticoagulation therapy and primary care internal medicine: A nurse practitioner model for combined clinical service
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
EA200700968A1 (ru) Фармацевтическая композиция для лечения сахарного диабета 2 типа
Gabra et al. Post-transfusion hepatitis.
BRAGIN Effects of prolonged exposure to acetic acid vapors on acid-base balance in humans(Abstract Only)
Frier et al. Hypertrophic osteoarthropathy and purgative abuse.
Sawyer THE MARCH MEETING OF THE STATE BOARD OF HEALTH